Agile Therapeutics, Inc. - Special Call
Llamada en conferencia Agile Therapeutics Inc
Agile Therapeutics Inc Conference call or earnings call will be held on 22-dic-2017 via an 800 number (toll-free). During the earnings conference call's session Agile Therapeutics Inc will provide updated information and financial status.
Conference call is also referred to as: teleconference call or audio conference bridge. Conferencing service is provided in house or as cloud based teleconference service.
In order to join the audio conferencing dial conference bridge and key in the PIN code, Contact Agile Therapeutics Inc for this information
Schedule a teleconference with QCONF and get 5 free calls with our conference service.
We are a forward-thinking women's healthcare company dedicated to fulfilling the unmet health needs of today's women. Our current product candidates are designed to provide women with contraceptive options that offer greater convenience and facilitate compliance. Our lead product candidate, Twirla®, also known as AG200-15, is a once-weekly prescription combination hormonal contraceptive patch that is at the end of Phase 3 clinical development. We completed the third of three Phase 3 clinical trials for Twirla in December 2016 and expect to resubmit our new drug application, or NDA, in the first half of 2017. Our short-term goal is to establish a market-leading franchise in the U.S. hormonal contraceptive market, which had total market sales of approximately $5.5 billion in 2016. Over half of those sales were generated by branded products.Leer más Llamada en conferencia